FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Gianluigi Giannelli

Research Profile

Disorders

Chemicals & Drugs

Physiology

Cell Movement

Anatomy

Tumor Cells, Cultured

Co-author Network

Publications

TOP 3
Antonio Mazzocca; Gianluigi Giannelli
Reply.
Emilia Fransvea; G Angarano; Salvatore Antonaci; V Bernabucci; A Mazzocca; M Milella; Nicola Napoli; M Quaranta; E Renna; R Sacco; Paolo Trerotoli; E Villa; Gianluigi Giannelli
SCCA-IC serum levels are predictive of clinical response in HCV chronic hepatitis to antiviral therapy: a multicentric prospective study.
Francesco Dituri; Charlotte E Edling; Marco Falasca; Salvatore Antonaci; Amalia Azzariti; Luigi Lupo; Antonio Mazzocca; Gianluigi Giannelli
PI3K class IB controls the cell cycle checkpoint promoting cell proliferation in hepatocellular carcinoma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Gianluigi Giannelli (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Antonio Mazzocca; Gianluigi Giannelli
Reply.
Hepatology (Baltimore, Md.) 2013;57(1):418-9.
2012: Emilia Fransvea; G Angarano; Salvatore Antonaci; V Bernabucci; A Mazzocca; M Milella; Nicola Napoli; M Quaranta; E Renna; R Sacco; Paolo Trerotoli; E Villa; Gianluigi Giannelli
SCCA-IC serum levels are predictive of clinical response in HCV chronic hepatitis to antiviral therapy: a multicentric prospective study.
Journal of viral hepatitis 2012;19(10):704-10.
2012: Francesco Dituri; Charlotte E Edling; Marco Falasca; Salvatore Antonaci; Amalia Azzariti; Luigi Lupo; Antonio Mazzocca; Gianluigi Giannelli
PI3K class IB controls the cell cycle checkpoint promoting cell proliferation in hepatocellular carcinoma.
International journal of cancer. Journal international du cancer 2012;130(11):2505-13.
2012: Francesca Baldassarre; Giuseppe Ciccarella; Flavia De Santis; Gianluigi Giannelli; Giovanna Lucarelli; Ross Rinaldi; Flavia Scarlino; Antonio Della Torre; Viviana Vergaro; Stefano Leporatti
Polyelectrolyte capsules as carriers for growth factor inhibitor delivery to hepatocellular carcinoma.
Macromolecular bioscience 2012;12(5):656-65.
2012: Gianluigi Giannelli
Editorial: TGF-β1 in pre-malignant and malignant liver disease.
Current pharmaceutical design 2012;18(27):4071.
2012: Viviana Vergaro; Francesca Baldassarre; Giuseppe Ciccarella; Flavia De Santis; Gianluigi Giannelli; Stefano Leporatti
TGF-beta inihibitor-loaded polyelectrolyte multilayers capsules for sustained targeting of hepatocarcinoma cells.
Current pharmaceutical design 2012;18(27):4155-64.
2012: Antonio Mazzocca; Salvatore Antonaci; Gianluigi Giannelli
The TGF-β signaling pathway as a pharmacological target in a hepatocellular carcinoma.
Current pharmaceutical design 2012;18(27):4148-54.
2011: Angela Santamato; Emilia Fransvea; Francesco Dituri; Alessandra Caligiuri; Michele Quaranta; Tomoaki Niimi; Massimo Pinzani; Salvatore Antonaci; Gianluigi Giannelli
Hepatic stellate cells stimulate HCC cell migration via laminin-5 production.
Clinical science (London, England : 1979) 2011;121(4):159-68.
2011: Emilia Fransvea; Salvatore Antonaci; Amalia Azzariti; Antonio Mazzocca; Angela Santamato; Gianluigi Giannelli
Kinase activation profile associated with TGF-β-dependent migration of HCC cells: a preclinical study.
Cancer chemotherapy and pharmacology 2011;68(1):79-86.
2011: Giovanna A Moscato; Gianluigi Giannelli; Barbara Grandi; Daniela Pieri; Ombretta Marsi; Isabella Guarducci; Irene Batini; Emanuele Altomare; Salvatore Antonaci; Alfonso Capria; Giovanni Pellegrini; Rodolfo Sacco
Quantitative determination of hepatitis C core antigen in therapy monitoring for chronic hepatitis C.
Intervirology 2011;54(2):61-5.
2011: Francesco Dituri; Gianluigi Giannelli; Antonio Mazzocca; Salvatore Antonaci
PI3K functions in cancer progression, anticancer immunity and immune evasion by tumors.
Clinical & developmental immunology 2011;2011():947858.
2010: Rosa Monno; Giovanni Pertosa; Giuseppe Grandaliano; Luciana Fumarola; Gianluigi Giannelli; Simone Simone
Relation of C. pneumoniae antibodies to inflammation and atherosclerosclerosis in dialysis patients.
Panminerva medica 2010;52(4):283-8.
2010: Rosa Monno; Luciana Fumarola; Paolo Trerotoli; Gianluigi Giannelli; Michele Correale; Daniele Brunetti; Matteo Di Biase
Seroprevalence of Chlamydophila pneumoniae in ischaemic heart disease.
The new microbiologica 2010;33(4):381-5.
2010: Antonella Daniele; A F Zito; Gianluigi Giannelli; R Divella; M Asselti; A Mazzocca; angelo paradiso; Michele Quaranta
Expression of metalloproteinases MMP-2 and MMP-9 in sentinel lymph node and serum of patients with metastatic and non-metastatic breast cancer.
Anticancer research 2010;30(9):3521-7.
2010: Antonio Mazzocca; Gianluigi Giannelli; Salvatore Antonaci
Involvement of ADAMs in tumorigenesis and progression of hepatocellular carcinoma: Is it merely fortuitous or a real pathogenic link?
Biochimica et biophysica acta 2010;1806(1):74-81.
2010: Antonio Mazzocca; Emilia Fransvea; Francesco Dituri; Luigi Lupo; Salvatore Antonaci; Gianluigi Giannelli
Down-regulation of connective tissue growth factor by inhibition of transforming growth factor beta blocks the tumor-stroma cross-talk and tumor progression in hepatocellular carcinoma.
Hepatology (Baltimore, Md.) 2010;51(2):523-34.
2009: Rosa Monno; Luciana Fumarola; Paolo Trerotoli; Domenica Cavone; Gianluigi Giannelli; Caterina Rizzo; Lorenzo Ciceroni; Marina Musti
Seroprevalence of Q fever, brucellosis and leptospirosis in farmers and agricultural workers in Bari, Southern Italy.
Annals of agricultural and environmental medicine : AAEM 2009;16(2):205-9.
2009: Luciana Fumarola; Rosa Monno; Enzo Ierardi; Giovanni Rizzo; Gianluigi Giannelli; Marco Lalle; Edoardo Pozio
Anisakis pegreffi etiological agent of gastric infections in two Italian women.
Foodborne pathogens and disease 2009;6(9):1157-9.
2009: Antonio Mazzocca; Emilia Fransvea; Gabriela Lavezzari; Salvatore Antonaci; Gianluigi Giannelli
Inhibition of transforming growth factor beta receptor I kinase blocks hepatocellular carcinoma growth through neo-angiogenesis regulation.
Hepatology (Baltimore, Md.) 2009;50(4):1140-51.
2009: Rosa Monno; Gianluigi Giannelli; Caterina Rizzo; Danila De Vito; Luciana Fumarola
Recombinant K39 immunochromatographic test for diagnosis of human leishmaniasis.
Future microbiology 2009;4(2):159-70.
2009: Emilia Fransvea; Antonio Mazzocca; Salvatore Antonaci; Gianluigi Giannelli
Targeting transforming growth factor (TGF)-betaRI inhibits activation of beta1 integrin and blocks vascular invasion in hepatocellular carcinoma.
Hepatology (Baltimore, Md.) 2009;49(3):839-50.
2009: Emilia Fransvea; angelo paradiso; Salvatore Antonaci; Gianluigi Giannelli
HCC heterogeneity: molecular pathogenesis and clinical implications.
Cellular oncology : the official journal of the International Society for Cellular Oncology 2009;31(3):227-33.
2009: Paolo Trerotoli; Emilia Fransvea; Umberto Angelotti; Giovanni Antonaci; Luigi Lupo; Antonio Mazzocca; Anita Mangia; Salvatore Antonaci; Gianluigi Giannelli
Tissue expression of Squamous Cellular Carcinoma Antigen (SCCA) is inversely correlated to tumor size in HCC.
Molecular cancer 2009;8():29.
2008: Luigi Lupo; Piercarmine Panzera; Francesco Tandoi; Giuseppe Carbotta; Gianluigi Giannelli; Teresa Santantonio; Maria Rendina; Antonella Gentile; vincenzo memeo
Basiliximab versus steroids in double therapy immunosuppression in liver transplantation: a prospective randomized clinical trial.
Transplantation 2008;86(7):925-31.
2008: Emilia Fransvea; Umberto Angelotti; Salvatore Antonaci; Gianluigi Giannelli
Blocking transforming growth factor-beta up-regulates E-cadherin and reduces migration and invasion of hepatocellular carcinoma cells.
Hepatology (Baltimore, Md.) 2008;47(5):1557-66.
2008: Gianluigi Giannelli; Concetta Sgarra; Letizia Porcelli; Amalia Azzariti; Salvatore Antonaci; angelo paradiso
EGFR and VEGFR as potential target for biological therapies in HCC cells.
Cancer letters 2008;262(2):257-64.
2008: Nicola Napoli; Gianluigi Giannelli; Alessandra Antonaci; Salvatore Antonaci
The use of different Peg-interferon alpha-2b regimens plus ribavirin in HCV-1b-infected patients after rapid virological response does not affect the achievement of sustained virological response.
Journal of viral hepatitis 2008;15(4):300-4.
2007: Carlo Bergamini; Concetta Sgarra; Paolo Trerotoli; Luigi Lupo; Amalia Azzariti; Salvatore Antonaci; Gianluigi Giannelli
Laminin-5 stimulates hepatocellular carcinoma growth through a different function of alpha6beta4 and alpha3beta1 integrins.
Hepatology (Baltimore, Md.) 2007;46(6):1801-9.
2007: Gianluigi Giannelli; Florenzo Iannone; Emilia Fransvea; A Chialà; Giovanni Lapadula; Salvatore Antonaci
Squamous cellular carcinoma immunocomplexed is increased in scleroderma patients with lung fibrosis.
Clinical and experimental rheumatology 2007;25(5):794-5.
2007: Michele Quaranta; Antonella Daniele; Maria Coviello; Maria Teresa Venneri; Ines Abbate; M E Caringella; S Di Tardo; R Divella; Paolo Trerotoli; M Di Gennaro; Francesco Schittulli; Emilia Fransvea; Gianluigi Giannelli
MMP-2, MMP-9, VEGF and CA 15.3 in breast cancer.
Anticancer research 2007;27(5B):3593-600.
2007: Gianluigi Giannelli; Emilia Fransvea; Paolo Trerotoli; Michel Beaugrand; Felice Marinosci; Luigi Lupo; Gisele Nkontchou; Pietro Dentico; Salvatore Antonaci
Clinical validation of combined serological biomarkers for improved hepatocellular carcinoma diagnosis in 961 patients.
Clinica chimica acta; international journal of clinical chemistry 2007;383(1-2):147-52.
2007: Luigi Lupo; Piercarmine Panzera; Gianluigi Giannelli; Maurizio Memeo; Antonella Gentile; vincenzo memeo
Single hepatocellular carcinoma ranging from 3 to 5 cm: radiofrequency ablation or resection?
HPB : the official journal of the International Hepato Pancreato Biliary Association 2007;9(6):429-34.
2007: Gianluigi Giannelli; Nicola Napoli; Salvatore Antonaci
Tyrosine kinase inhibitors: a potential approach to the treatment of hepatocellular carcinoma.
Current pharmaceutical design 2007;13(32):3301-4.
2007: Salvatore Antonaci; Gianluigi Giannelli
Rationale for new drugs targeting the tissue microenvironment in patients with HCC.
Current pharmaceutical design 2007;13(32):3288-91.
2007: Stefania Tommasi; Vita Fedele; Rosanna Lacalamita; Michele Bruno; Francesco Schittulli; David Ginzinger; Gery Scott; Serenella Eppenberger-Castori; Daniele Calistri; Silvia Casadei; Ian Seymour; Salvatore Longo; Gianluigi Giannelli; Brunella Pilato; Giuseppina Simone; Christopher C Benz; angelo paradiso
655Val and 1170Pro ERBB2 SNPs in familial breast cancer risk and BRCA1 alterations.
Cellular oncology : the official journal of the International Society for Cellular Oncology 2007;29(3):241-8.
2007: Gianluigi Giannelli; Concetta Sgarra; Edoardo Di Naro; C Lavopa; U Angelotti; Massimo Tartagni; Olivia Simone; Paolo Trerotoli; Salvatore Antonaci; Giuseppe Loverro
Endometriosis is characterized by an impaired localization of laminin-5 and alpha3beta1 integrin receptor.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2007;17(1):242-7.
2006: Gianluigi Giannelli; Francesco Saverio Vella; Salvatore Antonaci; C Foti; Raffaele Filotico
Tace treatment outcome: (almost) everything is predictable.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2006;38(12):940-1.
2006: Gianluigi Giannelli; Salvatore Antonaci
New frontiers in biomarkers for hepatocellular carcinoma.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2006;38(11):854-9.
2006: Gianluigi Giannelli; Salvatore Antonaci
Novel concepts in hepatocellular carcinoma: from molecular research to clinical practice.
Journal of clinical gastroenterology 2006;40(9):842-6.
2006: Francesco Saverio Vella; Gianluigi Giannelli; Giorgio Fiore; Salvatore Antonaci
[Extrapulmonary sarcoidosis with prevalent liver involvement: a new case and review of the literature].
Recenti progressi in medicina 2006;97(9):469-71.
2006: Gianluigi Giannelli; Florenzo Iannone; Felice Marinosci; Giovanni Lapadula; Salvatore Antonaci
Clinical outcomes of bosentan in pulmonary arterial hypertension do not correlate with levels of TIMPs.
European journal of clinical investigation 2006;36 Suppl 3():73-7.
2006: Gianluigi Giannelli; Carlo Bergamini; Felice Marinosci; Emilia Fransvea; Nicola Napoli; Patrick Maurel; Pietro Dentico; Salvatore Antonaci
Antifibrogenic effect of IFN-alpha2b on hepatic stellate cell activation by human hepatocytes.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2006;26(5):301-8.
2006: Gianluigi Giannelli; Amalia Azzariti; Concetta Sgarra; Letizia Porcelli; Salvatore Antonaci; angelo paradiso
ZD6474 inhibits proliferation and invasion of human hepatocellular carcinoma cells.
Biochemical pharmacology 2006;71(4):479-85.
2005: Gianluigi Giannelli; Felice Marinosci; Paolo Trerotoli; Anna Volpe; Michele Quaranta; Pietro Dentico; Salvatore Antonaci
SCCA antigen combined with alpha-fetoprotein as serologic markers of HCC.
International journal of cancer. Journal international du cancer 2005;117(3):506-9.
2005: Gianluigi Giannelli; Florenzo Iannone; Felice Marinosci; Michele Covelli; Giovanni Lapadula; Salvatore Antonaci
Infliximab therapy does not modify MMP-2 and MMP-9 serum concentrations in chronic arthritis.
Clinical and experimental rheumatology 2005;23(6):867-72.
2005: Gianluigi Giannelli; Carlo Bergamini; Emilia Fransvea; Concetta Sgarra; Salvatore Antonaci
Laminin-5 with transforming growth factor-beta1 induces epithelial to mesenchymal transition in hepatocellular carcinoma.
Gastroenterology 2005;129(5):1375-83.
2005: Francesco Saverio Vella; Elisabetta Panella; Nunzia Masciale; Gianluigi Giannelli; Salvatore Antonaci
[Clarkson syndrome: a rare clinical condition characterized by generalized edema associated to monoclonal gammopathy].
Recenti progressi in medicina 2005;96(10):488-91.
2005: Gianluigi Giannelli; Felice Marinosci; Concetta Sgarra; Luigi Lupo; Pietro Dentico; Salvatore Antonaci
Clinical role of tissue and serum levels of SCCA antigen in hepatocellular carcinoma.
International journal of cancer. Journal international du cancer 2005;116(4):579-83.
2005: Gianluigi Giannelli; Laura Minchella; Pier Luigi Lopalco; Grazia Mastromarco; Salvatore Antonaci
Treatment of community-acquired pneumonia: a descriptive study in an Apulian department of internal medicine.
Medical science monitor : international medical journal of experimental and clinical research 2005;11(9):CR434-9.
2005: Felice Marinosci; Carlo Bergamini; Emilia Fransvea; Nicola Napoli; Patrick Maurel; Pietro Dentico; Salvatore Antonaci; Gianluigi Giannelli
Clinical role of serum and tissue matrix metalloprotease-9 expression in chronic HCV patients treated with pegylated IFN-alpha2b and ribavirin.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2005;25(8):453-8.
2005: Gianluigi Giannelli; Salvatore Antonaci
Immunological and molecular aspects of liver fibrosis in chronic hepatitis C virus infection.
Histology and histopathology 2005;20(3):939-44.
2005: Gianluigi Giannelli; Florenzo Iannone; Felice Marinosci; Giovanni Lapadula; Salvatore Antonaci
The effect of bosentan on matrix metalloproteinase-9 levels in patients with systemic sclerosis-induced pulmonary hypertension.
Current medical research and opinion 2005;21(3):327-32.
2005: Salvatore Antonaci; Gianluigi Giannelli; Barbara Simone; Francesco Saverio Vella
[Syndrome of overlap: Chronic hepatitis C/autoimmune hepatitis: fact or fancy?].
Recenti progressi in medicina 2005;96(1):27-31.
2005: Nicola Napoli; Gianluigi Giannelli; Carmen Vita Parisi; Alessandra Antonaci; Grazia Maddalena; Salvatore Antonaci
Predictive value of early virological response to treatment with different interferon-based regimens plus ribavirin in patients with chronic hepatitis C.
The new microbiologica 2005;28(1):13-21.
2005: Gianluigi Giannelli; Anna De Marzo; Felice Marinosci; Salvatore Antonaci
Matrix metalloproteinase imbalance in muscle disuse atrophy.
Histology and histopathology 2005;20(1):99-106.
2004: Gianluigi Giannelli; Amalia Azzariti; Emilia Fransvea; Letizia Porcelli; Salvatore Antonaci; angelo paradiso
Laminin-5 offsets the efficacy of gefitinib ('Iressa') in hepatocellular carcinoma cells.
British journal of cancer 2004;91(11):1964-9.
2004: Gianluigi Giannelli; Graziana Guadagnino; Pietro Dentico; Guido Antonelli; Salvatore Antonaci
MxA and PKR expression in chronic hepatitis C.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2004;24(11):659-63.
2004: Gianluigi Giannelli; R Erriquez; Florenzo Iannone; Felice Marinosci; Giovanni Lapadula; Salvatore Antonaci
MMP-2, MMP-9, TIMP-1 and TIMP-2 levels in patients with rheumatoid arthritis and psoriatic arthritis.
Clinical and experimental rheumatology 2004;22(3):335-8.
2004: Gianluigi Giannelli; Roberta Erriquez; Emilia Fransvea; Antonella Daniele; Paolo Trerotoli; Francesco Schittulli; Maria Grano; Michele Quaranta; Salvatore Antonaci
Proteolytic imbalance is reversed after therapeutic surgery in breast cancer patients.
International journal of cancer. Journal international du cancer 2004;109(5):782-5.
2003: Gianluigi Giannelli; Vito Quaranta; Salvatore Antonaci
Tissue remodelling in liver diseases.
Histology and histopathology 2003;18(4):1267-74.
2003: Gianluigi Giannelli; Emilia Fransvea; Carlo Bergamini; Felice Marinosci; Salvatore Antonaci
Laminin-5 chains are expressed differentially in metastatic and nonmetastatic hepatocellular carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(10 Pt 1):3684-91.
2003: Vito Quaranta; Gianluigi Giannelli
Cancer invasion: watch your neighbourhood!
Tumori 2003;89(4):343-8.
2003: Francesco Saverio Vella; Barbara Simone; Gianluigi Giannelli; MariaTeresa Pesolo; Giuseppe Ingravallo; Antonia Gentile; Salvatore Antonaci
Case of multiple myeloma mimicking an infectious disease with fever, intrahepatic cholestasis, renal failure, and pulmonary insufficiency.
American journal of hematology 2003;72(1):38-42.
2002: Gianluigi Giannelli; Francesca Pierri; Oronzo Schiraldi; Salvatore Antonaci
[Diarrhea as first clinical manifestation of hepatocellular carcinoma].
Recenti progressi in medicina 2002;93(9):478-81.
2002: Francesco Saverio Vella; Barbara Simone; Gianluigi Giannelli; Dario Sisto; Carlo Sborgia; Salvatore Antonaci
Glaucoma in primary amyloidosis: a fortuitous or causative association?
The American journal of medicine 2002;113(3):252-4.
2002: Roberta Faccio; Maria Grano; Silvia Colucci; Antonello Villa; Gianluigi Giannelli; Vito Quaranta; Alberta Zallone
Localization and possible role of two different alpha v beta 3 integrin conformations in resting and resorbing osteoclasts.
Journal of cell science 2002;115(Pt 14):2919-29.
2002: Maria Grano; Giorgio Mori; Vincenza Minielli; Silvia Colucci; S Vaira; Gianluigi Giannelli; S Martemucci; Francesco Giorgino; Alberta Zallone
HGF and M-CSF modulate adhesion of MDA-231 breast cancer cell by increasing osteopontin secretion.
Journal of biological regulators and homeostatic agents 2002;16(3):190-5.
2002: Caterina Foti; Gianluigi Giannelli; A Berloco; V Mascolo; Giuseppe Ingravallo; Carmela Giardina
Malignant fibrous histiocytoma arising on chronic osteomyelitis.
Journal of the European Academy of Dermatology and Venereology : JEADV 2002;16(4):390-2.
2002: Gianluigi Giannelli; Emilia Fransvea; Felice Marinosci; Carlo Bergamini; Silvia Colucci; Oronzo Schiraldi; Salvatore Antonaci
Transforming growth factor-beta1 triggers hepatocellular carcinoma invasiveness via alpha3beta1 integrin.
The American journal of pathology 2002;161(1):183-93.
2002: Gianluigi Giannelli; Anna De Marzo; Carolina Scagnolari; Carlo Bergamini; Emilia Fransvea; Francesca Bagnato; Francesca Bellomi; Enrico Millefiorini; Claudio Gasperini; Salvatore Antonaci; Guido Antonelli
Proteolytic balance in patients with multiple sclerosis during interferon treatment.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2002;22(6):689-92.
2002: Gianluigi Giannelli; Caterina Foti; Felice Marinosci; Domenico Bonamonte; Salvatore Antonaci; Gianni Angelini
Gelatinase expression at positive patch test reactions.
Contact dermatitis 2002;46(5):280-5.
2002: Gianluigi Giannelli; Emilia Fransvea; Felice Marinosci; Carlo Bergamini; Antonella Daniele; Silvia Colucci; angelo paradiso; Michele Quaranta; Salvatore Antonaci
Gelatinase levels in male and female breast cancer.
Biochemical and biophysical research communications 2002;292(1):161-6.
2002: Maria Grano; Giorgio Mori; Vincenza Minielli; Odile Barou; Silvia Colucci; Gianluigi Giannelli; Christian Alexandre; Alberta Zallone; Laurence Vico
Rat hindlimb unloading by tail suspension reduces osteoblast differentiation, induces IL-6 secretion, and increases bone resorption in ex vivo cultures.
Calcified tissue international 2002;70(3):176-85.
2002: Gianluigi Giannelli; Carlo Bergamini; Felice Marinosci; Emilia Fransvea; Michele Quaranta; Luigi Lupo; Oronzo Schiraldi; Salvatore Antonaci
Clinical role of MMP-2/TIMP-2 imbalance in hepatocellular carcinoma.
International journal of cancer. Journal international du cancer 2002;97(4):425-31.
2002: Gianluigi Giannelli; Simonetta Astigiano; Salvatore Antonaci; Monica Morini; Ottavia Barbieri; Douglas M Noonan; Adriana Albini
Role of the alpha3beta1 and alpha6beta4 integrins in tumor invasion.
Clinical & experimental metastasis 2002;19(3):217-23.
2002: Gianluigi Giannelli; Salvatore Antonaci
Gelatinases and their inhibitors in tumor metastasis: from biological research to medical applications.
Histology and histopathology 2002;17(1):339-45.
2001: Gianluigi Giannelli; L Milillo; Felice Marinosci; Lorenzo Lo Muzio; Rosario Serpico; Salvatore Antonaci
Altered expression of integrins and basement membrane proteins in malignant and pre-malignant lesions of oral mucosa.
Journal of biological regulators and homeostatic agents 2001;15(4):375-80.
2001: Gianluigi Giannelli; Carlo Bergamini; Emilia Fransvea; Felice Marinosci; Vito Quaranta; Salvatore Antonaci
Human hepatocellular carcinoma (HCC) cells require both alpha3beta1 integrin and matrix metalloproteinases activity for migration and invasion.
Laboratory investigation; a journal of technical methods and pathology 2001;81(4):613-27.
2001: William B Kiosses; Klaus M Hahn; Gianluigi Giannelli; Vito Quaranta
Characterization of morphological and cytoskeletal changes in MCF10A breast epithelial cells plated on laminin-5: comparison with breast cancer cell line MCF7.
Cell communication & adhesion 2001;8(1):29-44.
2000: Naohiko Koshikawa; Gianluigi Giannelli; Vincenzo Cirulli; K Miyazaki; Vito Quaranta
Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5.
The Journal of cell biology 2000;148(3):615-24.
2000: Gianluigi Giannelli; Salvatore Antonaci
Biological and clinical relevance of Laminin-5 in cancer.
Clinical & experimental metastasis 2000;18(6):439-43.
1999: Gianluigi Giannelli; Ambra Pozzi; William Stetler-Stevenson; Humphrey A Gardner; Vito Quaranta
Expression of matrix metalloprotease-2-cleaved laminin-5 in breast remodeling stimulated by sex steroids.
The American journal of pathology 1999;154(4):1193-201.
1997: Gianluigi Giannelli; J Falk-Marzillier; Oronzo Schiraldi; William Stetler-Stevenson; Vito Quaranta
Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5.
Science (New York, N.Y.) 1997;277(5323):225-8.
1996: Giuseppina Piazzolla; Gianluigi Giannelli; Guido Antonelli; Cosimo Tortorella; Emilio Jirillo; Oronzo Schiraldi; Salvatore Antonaci
Effects of interferon-alpha treatment on neutrophil oxidative metabolism, lymphocyte proliferation and monocyte HLA class I antigen expression in patients with chronic hepatitis C.
Immunopharmacology and immunotoxicology 1996;18(4):529-48.
1996: George E Plopper; J Falk-Marzillier; S Glaser; M Fitchmun; Gianluigi Giannelli; T Romano; Jonathan C R Jones; Vito Quaranta
Changes in expression of monoclonal antibody epitopes on laminin-5r induced by cell contact.
Journal of cell science 1996;109 ( Pt 7)():1965-73.
1996: Guido Antonelli; Gianluigi Giannelli; M Currenti; E Simeoni; S Del Vecchio; Fabrizio Maggi; Mauro Pistello; L Roffi; Giuseppe Pastore; L Chemello; Ferdinando NMN Dianzani
Antibodies to interferon (IFN) in hepatitis C patients relapsing while continuing recombinant IFN-alpha2 therapy.
Clinical and experimental immunology 1996;104(3):384-7.
1996: Silvia Colucci; Gianluigi Giannelli; Maria Grano; R Faccio; Vito Quaranta; A Z Zallone
Human osteoclast-like cells selectively recognize laminin isoforms, an event that induces migration and activates Ca2+ mediated signals.
Journal of cell science 1996;109 ( Pt 6)():1527-35.
1996: Gianluigi Giannelli; J Brassard; C Foti; William Stetler-Stevenson; J Falk-Marzillier; A Zambonin-Zallone; Oronzo Schiraldi; Vito Quaranta
Altered expression of basement membrane proteins and their integrin receptors in lichen planus: possible pathogenetic role of gelatinases A and B.
Laboratory investigation; a journal of technical methods and pathology 1996;74(6):1091-104.
1995: M Milella; Guido Antonelli; Teresa Santantonio; Gianluigi Giannelli; M Currenti; Laura Monno; Ombretta Turriziani; Giuseppe Pastore; Ferdinando NMN Dianzani
Treatment with natural IFN of hepatitis C patients with or without antibodies to recombinant IFN.
Hepato-gastroenterology 1995;42(3):201-4.
1994: Guido Antonelli; Gianluigi Giannelli; Mauro Pistello; Fabrizio Maggi; L Vatteroni; M Currenti; S Del Vecchio; L Roffi; Giuseppe Pastore; Ferdinando NMN Dianzani
Clinical significance of recombinant interferon-alpha 2 neutralizing antibodies in hepatitis patients.
Journal of interferon research 1994;14(4):211-3.
1994: Gianluigi Giannelli; Guido Antonelli; G Fera; S Del Vecchio; E Riva; C Broccia; Oronzo Schiraldi; Ferdinando NMN Dianzani
Biological and clinical significance of neutralizing and binding antibodies to interferon-alpha (IFN-alpha) during therapy for chronic hepatitis C.
Clinical and experimental immunology 1994;97(1):4-9.
1994: Gianluigi Giannelli; P Savoia; Oronzo Schiraldi; M Lospalluti; M De Luca; P C Marchisio; Vito Quaranta
Psoriatic lesions in patients with chronic liver disease are distinct from psoriasis vulgaris lesions, as judged on basis of integrin adhesion receptors.
Hepatology (Baltimore, Md.) 1994;20(1 Pt 1):56-65.
1993: Gianluigi Giannelli; Guido Antonelli; G Fera; Ferdinando NMN Dianzani; Oronzo Schiraldi
2',5'-Oligoadenylate synthetase activity as a responsive marker during interferon therapy for chronic hepatitis C.
Journal of interferon research 1993;13(1):57-60.
1993: N Napoli; Giorgio Fiore; G Fera; A Modugno; Gianluigi Giannelli; O G Manghisi; Oronzo Schiraldi
Occurrence of hepatitis delta virus infection in hepatitis B virus-infected patients with different serum patterns of preS gene-encoded proteins.
Digestion 1993;54(1):9-14.
1991: Giorgio Fiore; N Napoli; G Fera; Gianluigi Giannelli; A Perricci; G Lonero; Oronzo Schiraldi
Hepatitis C virus infection in anti-HBe-positive HBsAg carriers with chronic liver disease.
Digestion 1991;50(3-4):121-6.
1989: Oronzo Schiraldi; Gianluigi Giannelli; G Fera
[Munchausen syndrome. Apropos of a case].
Recenti progressi in medicina 1989;80(3):133-6.